Full Name
YONG WEI PENG
Variants
Yong, W.-P.
Yong, W.P.
Peng, Y.W.
 
 
 
Email
csiywp@nus.edu.sg
 

Publications

Results 1-20 of 57 (Search time: 0.068 seconds).

Issue DateTitleAuthor(s)
1May-2012A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targetsDeng, N. ; Goh, L.K. ; Wang, H.; Das, K. ; Tao, J.; Tan, I.B.; Zhang, S.; Lee, M.; Wu, J.; Lim, K.H.; Lei, Z.; Goh, G.; Lim, Q.-Y.; Tan, A.L.-K.; Poh, D.Y.S.; Riahi, S.; Bell, S.; Shi, M.M.; Linnartz, R.; Zhu, F.; Yeoh, K.G.; Toh, H.C.; Yong, W.P. ; Cheong, H.C.; Rha, S.Y.; Boussioutas, A.; Grabsch, H.; Rozen, S. ; Tan, P. 
2Jul-2006A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancerSoo, R.A. ; Wang, L.Z. ; Tham, L.S.; Yong, W.P. ; Boyer, M.; Lim, H.L.; Lee, H.S.; Millward, M.; Liang, S.; Beale, P.; Lee, S.C. ; Goh, B.C.
310-Oct-2016A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activationOng, Pei-Shi ; Wang, Lingzhi ; Chia, Deborah Miao-Hui; Seah, Jolyn Yu-Xin; Kong, Li-Ren ; Thuya, Win-Lwin ; Chinnathambi, Arunachalam; Lau, Jie-Ying Amelia ; Wong, Andrea Li-Ann ; Yong, Wei-Peng ; Yang, Daiwen ; Ho, Paul Chi-Lui ; Sethi, Gautam ; Goh, Boon-Cher 
4Jul-2008A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancersYong, W.-P. ; Wang, L.-Z. ; Tham, L.-S.; Wong, C.-I.; Lee, S.-C. ; Soo, R. ; Sukri, N.; Lee, H.-S.; Goh, B.-C.
52018A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancerSundar, R ; Rha, S.Y; Yamaue, H; Katsuda, M; Kono, K ; Kim, H.S; Kim, C; Mimura, K; Kua, L.-F ; Yong, W.P 
62018A review on liquid chromatography-tandem mass spectrometry methods for rapid quantification of oncology drugsWong, A.L.-A ; Xiang, X; Ong, P.S ; Mitchell, E.Q.Y; Syn, N; Wee, I; Kumar, A.P ; Yong, W.P ; Sethi, G ; Goh, B.C ; Ho, P.C.-L ; Wang, L 
72018A sensitive liquid chromatography-tandem mass spectrometry method for the determination of nimbolide in mouse serum: Application to a preclinical pharmacokinetics studyWang, L ; Khoa Phan, D.-D; Syn, N; Xiang, X; Song, H; Thuya, W.L ; Yang, S ; Wong, A.L.-A ; Kumar, A.P ; Yong, W.P ; Sethi, G ; Ho, P.C.-L ; Goh, B.C 
82018Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressorSubhash, V.V; Yeo, M.S; Wang, L ; Tan, S.H; Wong, F.Y; Thuya, W.L ; Tan, W.L; Peethala, P.C ; Soe, M.Y; Tan, D.S.P; Padmanabhan, N ; Baloglu, E; Shacham, S; Tan, P ; Koeffler, H.P ; Yong, W.P 
92016Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its developmentWang, L ; Khoa Phan, D.D; Zhang, J; Ong, P.-S ; Thuya, W.L ; Soo, R.A ; Wong, A.L.-A ; Yong, W.P ; Lee, S.C ; Ho, P.C.-L ; Sethi, G ; Goh, B.C 
1010-Jun-2012Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A biomarker evaluation from the AVAGAST randomized phase III trialVan Cutsem, E.; De Haas, S.; Kang, Y.-K.; Ohtsu, A.; Tebbutt, N.C.; Xu, J.M.; Yong, W.P. ; Langer, B.; Delmar, P.; Scherer, S.J.; Shah, M.A.
112016CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancerRoy R.K. ; Hoppe M.M. ; Srivastava S. ; Samanta A. ; Sharma N.; Tan K.T. ; Yang H.; Voon D.C. ; Pang B. ; Teh M. ; Murata-Kamiya N.; Hatakeyama M.; Chang Y.-T. ; Yong W.P. ; Ito Y. ; Ho K.Y. ; Tan P. ; Soong R. ; Koeffler P.H.; Yeoh K.G. ; Jeyasekharan A.D. 
12Dec-2012Clinical Impact of Drug-Drug Interaction Between Aspirin and Prednisolone at a Cancer CenterKoomanan, N.; Ko, Y. ; Yong, W.-P. ; Ng, R.; Wong, Y.-P.; Lim, S.-W. ; Salim, A. ; Chan, A. 
13May-2009Clinical pharmacology and pharmacogenetics of gemcitabineWong, A.; Soo, R.A. ; Yong, W.-P. ; Innocenti, F.
144-Dec-2012Combination Therapy with Gossypol Reveals Synergism against Gemcitabine Resistance in Cancer Cells with High BCL-2 ExpressionWong, F.Y.; Liem, N.; Xie, C.; Yan, F.L.; Wong, W.C.; Wang, L. ; Yong, W.-P. 
152017Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1Wang, L ; Chan, C.E.L; Wong, A.L.-A ; Wong, F.C; Lim, S.W ; Chinnathambi, A; Alharbi, S.A; Lee, L.S.-U ; Soo, R ; Yong, W.P ; Lee, S.C ; Ho, P.C.-L ; Sethi, G ; Goh, B.C 
1621-May-2010Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular featuresAng, P.W.; Loh, M. ; Liem, N.; Lim, P.L.; Grieu, F.; Vaithilingam, A.; Platell, C.; Yong, W.P. ; Iacopetta, B.; Soong, R. 
1713-Mar-2014Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancerGoh, L.K.; Liem, N.; Vijayaraghavan, A.; Chen, G.; Lim, P.L.; Tay, K.-J.; Chang, M.; Low, J.S.W.; Joshi, A.; Huang, H.H.; Kalaw, E.; Tan, P.H.; Hsieh, W.-S.; Yong, W.P. ; Alumkal, J.; Sim, H.G.
182018Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapyLimviphuvadh, V; Tan, C.S; Konishi, F; Jenjaroenpun, P; Xiang, J.S; Kremenska, Y; Mu, Y.S; Syn, N; Lee, S.C; Soo, R.A ; Eisenhaber, F ; Maurer-Stroh, S ; Yong, W.P 
1928-Mar-2014DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: A comprehensive profiling approachLoh, M.; Liem, N.; Vaithilingam, A.; Lim, P.L.; Sapari, N.S.; Elahi, E.; Mok, Z.Y.; Cheng, C.L.; Yan, B.; Pang, B.; Salto-Tellez, M. ; Yong, W.P. ; Iacopetta, B.; Soong, R.
20Mar-2013Effects of Hepatic Impairment on the Pharmacokinetics of Everolimus: A Single-Dose, Open-Label, Parallel-Group StudyPeveling-Oberhag, J.; Zeuzem, S.; Yong, W.P. ; Kunz, T.; Paquet, T.; Bouillaud, E.; Urva, S.; Anak, O.; Sellami, D.; Kobalava, Z.